FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/098482 [Registered on: 04/12/2025] Trial Registered Prospectively
Last Modified On: 03/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective analysis of retrospectively collected data 
Study Design  Other 
Public Title of Study   A study to identify patients with anaemia before cancer surgery 
Scientific Title of Study   Retrospective study of prevalence of anaemia and impact of anaemia management in the perioperative period 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
5009_Version 1.1 dated 28.10.2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vandana Agarwal  
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anaesthesia,Critical care and pain, Tata Memorial Hospital, Parel, Mumbai 400012

Mumbai
MAHARASHTRA
400012
India 
Phone  02241770004042  
Fax    
Email  vandanachaukar@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vandana Agarwal  
Designation  Professor 
Affiliation  Tata Memorial Hospital 
Address  Department of Anaesthesia,Critical care and pain, Tata Memorial Hospital, Parel, Mumbai 400012

Mumbai
MAHARASHTRA
400012
India 
Phone  02241770004042  
Fax    
Email  vandanachaukar@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shivanand 
Designation  Junior resident 
Affiliation  Tata memorial hospital Mumbai 
Address  Department of Anaesthesia, Crtical care and Pain Tata memorial hospital Parel, Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone  7259846668  
Fax    
Email  22shivumalage@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia,Critical care and pain, Tata Memorial Hospital, Parel, Mumbai 400012, India 
 
Primary Sponsor  
Name  Tata Memorial Hospital 
Address  Dr.E Borges Road,Parel,Mumbai 400012 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vandana Agarwal  Tata Memorial Hospital   Department of Anaesthesia, Critical Care,Pain, Tata Memorial Hospital, Ernest Borges Road, Parel East, Mumbai-400012
Mumbai
MAHARASHTRA 
02241770004042

vandanachaukar@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Tata Memorial Hospital_Institutional Ethics Committee I  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1.Patients who visited the PAC for the planned diagnostic and therapeutic procedure.Only the index cases will be considered for this study 
 
ExclusionCriteria 
Details  1. Patients age less than 18 years
2. Pregnant women
3. patients whom preoperative hemoglobin levels within 1 month are not available
4.More than 50 percent data cannot be retrieved from the electronic medical record 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. To study the prevalence of preoperative anaemia in patients who visited the PAC (Pre anaesthesia Clinic)  Over a period of a month from 1st January to 31st January 2025 
 
Secondary Outcome  
Outcome  TimePoints 
1. To study current perioperative anaemia management startgies,such as detection and diagnosis of anaemia , preoperative anaemia correction and change in haemoglobin before the surgery
2.Intraopertive blood loos and blood transfusion rate
3. Predischarge haemoglobin and hematinic prescription  
Over a period of a month from 1st January to 31st January 
 
Target Sample Size   Total Sample Size="1500"
Sample Size from India="1500" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The purpose of this study is to study the prevalence of anemia in patients planned for elective cancer surgery at Tata Memorial Hospital. In addition, we will audit current anemia management strategies and their impact on patient’s hemoglobin before surgery, their course in the hospital, and at discharge. Patients who visited the pre-anesthesia clinic for surgical fitness from  1st January – 31st January 2025 will be included in this study. We will be collecting the data from the electronic medical record, prescription information, investigation, and pre-anesthesia clinic records.

Since this is a retrospective study, no additional tests will be done. There will be no additional cost incurred. No reimbursement will be required/done for this study since there are no risks involved.

Results of this study will help us understand the anemia burden before surgery in our patients. It will also give us insight regarding the effectiveness of anemia management strategies before surgery. This information will help in improving the care delivered to our patients in the future. Information will be available to the investigators and the institutional ethics committee 
Close